“Bruce had a brilliant career in both academia and industry and left an indelible mark on the Alzheimer’s disease drug development landscape,” noted Robert Vassar, Northwestern University, Chicago ...
In recent years, CryoEM has enabled scientists to decipher the structures of the fibrils that form various deposits in neurodegenerative disease. They have not only solved disease-specific folding ...
Seeking ways to improve the safety of anti-amyloid antibodies, John Sims of Eli Lilly & Company presented a simple option to do so for donanemab at this year’s Clinical Trials on Alzheimer’s Disease ...
SORL1 knockout, knockin, and transgenic mice are now in the Research Models database. The database will be updated as more models become available.
Already have an account? Log in.
Wayne Shotts, Physics Ph.D., B.A.
You are not authorized to access this site.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback